Rubicon Genomics Announces Clinical Supply Agreement with Agendia



Published:

ANN ARBOR -- Rubicon Genomics, Inc., a company developing and commercializing sample-specific pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms, today announced a clinical supply agreement with molecular diagnostics firm Agendia for its TransPLEX whole genome RNA amplification technology. Agendia will incorporate Rubicon's TransPLEX kits into the analysis of FFPE (formalin-fixed, paraffin-embedded) patient samples for use with its Symphony suite of breast cancer diagnostics.

"This agreement marks an important milestone for Rubicon," said Rubicon CEO James Koziarz.  "Our innovative sample-specific technologies for improving the performance of DNA and RNA analytic platforms are being used in an increasingly broad range of applications. This supply agreement with cancer diagnostics pioneer Agendia represents our first large-scale commercial partnership with a provider of clinical diagnostic tests, and we expect it to be the first of many going forward."

FFPE tumor samples are widely used in cancer diagnostics, but they present many challenges for molecular analysis. RNA or DNA extracted from FFPE samples is highly fragmented and often contains only small amounts of usable DNA or RNA, which may be insufficient for analysis.  Rubicon's TransPLEX genomic RNA amplification kits and GenomePLEX genomic DNA amplification kits are members of Rubicon's OmniPLEX family of technologies that are designed and validated to overcome these problems and deliver sufficient quantities of high quality nucleic acids to enable accurate and consistent analyses.

"Rubicon's TransPLEX RNA amplification technology for FFPE samples was a standout in our evaluation of the available options for use with our Symphony products for the diagnosis and management of breast cancer," commented David Macdonald, CEO of Agendia. "TransPLEX offers product performance and workflow advantages, producing superior results while taking less time.  In line with our commitment to ongoing innovation and product excellence, we look forward to incorporating this superior technology into our ongoing diagnostic operations."

Rubicon's OmniPLEX amplification kits use proprietary methods for advanced library synthesis and high-yield amplification to prepare samples for sensitive and accurate PCR, microarray and next-generation sequencing analysis for use in biomedical research and clinical medicine. 

Financial details of the agreement were not disclosed.

Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Related Articles

Detroit Tigers Announce Partnership With Uber

With only two days until Tigers Opening Day at Comerica Park, the Detroit Tigers today announced a partnership with mobile ridesharing company Uber, naming them the team’s official ride-sharing company. This season, there will be a dedicated pick-up and drop-off zone for fans choosing to Uber to and from Comerica Park, located on the northbound side of the I-75 service drive, between John R and Brush Street.

Detroit Pistons and Henry Ford Health System Partner on Training, Rehab, and Sports Medicine Complex  

The Detroit Pistons and Henry Ford Health System today announced plans to build a new 100,000-square-foot training, rehabilitation, and sports medicine complex in Detroit’s New Center area. The site is bordered by Amsterdam Street, Second and Third Avenues, and a set of railroad tracks to the north. Construction is expected to begin this summer.

Ford Invests $1B in Argo AI, Works Towards Leading Autonomous Vehicle Market

Dearborn-based automaker Ford Motor Co. today announced a $1 billion investment in Pittsburgh-based Argo AI over the next five years, to develop a virtual driver system for the autonomous vehicle Ford has planned for 2021, and for potential licensing opportunities.

Meridian Winter Blast Set to Coincide With North American International Auto Show

The thirteenth annual Meridian Winter Blast, presented by Quicken Loans, has been moved up several weeks and is now scheduled to coincide with the final weekend of the North American International Auto Show — January 20-22.

Detroit Pistons to Move to Downtown in 2017, will Generate Additional $596.2M in Economic Impact

Agreements under which the Pistons will move to downtown Detroit and begin playing next season at the new Little Caesars Arena in The District Detroit, a $1.2 billion sports and entertainment development, have been announced today.
Edit ModuleShow Tags

Most Popular

  1. Crown Enterprises in Warren Confirms Sale of Detroit’s Michigan Central Depot to Ford Motor Co.
    Matthew Moroun, chairman of Crown Enterprises Inc. in Warren, today announced that the company...
  2. Luxury Housing Developments Planned for Royal Oak, Birmingham
    Two new luxury housing developments are being built in Birmingham and Royal Oak. The Park West...
  3. Line of Flight
    A longer runway at Cherry Capital Airport in Traverse City, new golf courses and wineries,...
  4. Faurecia in Auburn Hills Partners With Chinese Automobile Manufacturer
    Auburn Hills’ Faurecia, an automotive technology company, today signed a strategic partnership...
  5. Jefferson Beach Marina in St. Clair Shores and Toledo Beach Marina in La Salle Acquired by Dallas Company
    Safe Harbor Marinas in Dallas has announced the acquisition of two marinas in Michigan –...
  6. Holland, Mich.’s JR Automation Acquires Auburn Hills’ Esys Automation
    JR Automation, a Holland, Mich.-based provider of intelligent automated manufacturing and...